KeyCorp Lowers HCA Healthcare (NYSE:HCA) Price Target to $420.00

HCA Healthcare (NYSE:HCA) had its target price decreased by analysts at KeyCorp from $475.00 to $420.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. KeyCorp’s target price indicates a potential upside of 16.42% from the stock’s previous close.

HCA has been the subject of several other research reports. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Barclays increased their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Oppenheimer increased their target price on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Royal Bank of Canada increased their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Finally, Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $379.11.

HCA Healthcare Stock Up 1.2 %

HCA Healthcare stock opened at $360.75 on Monday. The company has a 50-day simple moving average of $394.42 and a 200-day simple moving average of $353.21. The firm has a market capitalization of $94.49 billion, a P/E ratio of 17.98, a P/E/G ratio of 1.52 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare has a one year low of $222.23 and a one year high of $417.14.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is owned by insiders.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds have recently added to or reduced their stakes in HCA. Bangor Savings Bank increased its holdings in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares during the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the second quarter valued at approximately $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare during the second quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC grew its holdings in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare during the second quarter valued at approximately $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.